|
Q2 FY2027
As of Aug 31, 2026
|
Q1 FY2027
As of May 31, 2026
|
Q4 FY2026
As of Feb 28, 2026
|
Q3 FY2026
As of Nov 30, 2025
|
Q2 FY2026
As of Aug 31, 2025
|
Q1 FY2026
As of May 31, 2025
|
Q4 FY2025
As of Feb 28, 2025
|
Q3 FY2025
As of Nov 30, 2024
|
Q2 FY2025
As of Aug 31, 2024
|
Q1 FY2025
As of May 31, 2024
|
Q4 FY2024
As of Feb 29, 2024
|
Q3 FY2024
As of Nov 30, 2023
|
Q2 FY2024
As of Aug 31, 2023
|
Q1 FY2024
As of May 31, 2023
|
Q4 FY2023
As of Feb 28, 2023
|
Q3 FY2023
As of Nov 30, 2022
|
Q2 FY2023
As of Aug 31, 2022
|
Q1 FY2023
As of May 31, 2022
|
Q4 FY2022
As of Feb 28, 2022
|
Q3 FY2022
As of Nov 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Account receivable - oil & gas | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Oil and Gas Property - Full Cost Method | ||||||||||||||||||||
| Properties subject to depletion | ||||||||||||||||||||
| Less: accumulated depletion and impairment | ||||||||||||||||||||
| Total Oil and Gas Property, net | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Convertible note payable - related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible note payable - related party | ||||||||||||||||||||
| Accounts payable and accrued expenses - related party | ||||||||||||||||||||
| Accounts payable and accrued expenses - related party - long-term | ||||||||||||||||||||
| Accounts payable and accrued expenses - related parties-long term | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Series A Convertible Preferred stock, $0.0001 par value per share 1,000,000 shares authorized; nil and 1,000,000 shares issued and outstanding as of February 28, 2026 and 2025, respectively; liquidation preference of $2,250,000 | ||||||||||||||||||||
| Stockholders’ Deficit | ||||||||||||||||||||
| Preferred stock, $0.001 par value per share 20,000,000 shares authorized | ||||||||||||||||||||
| Common stock, $0.001 par value per share, 150,000,000 shares authorized; 108,245,688 shares issued and outstanding as of periods ending February 28, 2026 and August 31, 2026 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholder’s Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
Loading...
